Recombinant Human B-cell receptor CD22 (CD22), partial, Active Protein

Protein

Unconjugated, C-Terminal 6Xhis-Tagged

-20°C. Avoid repeated freeze/thaw cycles.

Cancer

Active Recombinant Protein

For Research Use Only. Not for use in diagnostic procedures.

Refer to the datasheet/CoA included in the product pouch.

This product is manufactured at ISO 9001 certified facilities.

Recombinant Human B-cell receptor CD22 (CD22), partial, Active Protein is a purified Active Recombinant Protein. Purity: >90% as determined by SDS-PAGE. Host: Mammalian Cell. Endotoxin Level: <1.0 EU/ug as determined by LAL method. Species: Human (Homo sapiens). Target Name: CD22. Target Synonyms: B-lymphocyte cell adhesion molecule (BL-CAM; Sialic acid-binding Ig-like lectin 2; Siglec-2; T-cell surface antigen Leu-14; CD22). Accession Number: P20273. Expression Region: 20~687aa. Tag Info: C-Terminal 6Xhis-Tagged. Theoretical MW: 77.9kDa. Buffer: Lyophilized from a 0.2 um filtered 20 mM Tris-HCl, 0.5 M NaCl, 6% Trehalose, pH 8.0 Storage: -20°C. Avoid repeated freeze/thaw cycles. Restrictions: For Research Use Only. Not for use in diagnostic procedures.

Lyophilized from a 0.2 um filtered 20 mM Tris-HCl, 0.5 M NaCl, 6% Trehalose, pH 8.0